Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice. Issue 5 (23rd October 2022)

• Record Type: Journal Article
• Authors: Francke, Marith I.; Peeters, Laura E. J.; Hesselink, Dennis A.; Kloosterboer, Sanne M.; Koch, Birgit C. P.; Veenhof, Herman; de Winter, Brenda C. M.
• Is Part Of: Therapeutic drug monitoring. Volume 44:Issue 5(2022)
• Page Start: 696
• Page End: 700
• Publication Date: 2022-10-23
• Subjects: dried blood spot -- therapeutic drug monitoring -- adherence -- home sampling; Pharmacokinetics -- Periodicals; Patient monitoring -- Periodicals; Drugs -- Analysis -- Periodicals; Body fluids -- Analysis -- Periodicals; Drug Therapy -- Periodicals; Monitoring, Physiologic -- Periodicals; Pharmacology -- Periodicals; 615.7
• DOI: 10.1097/FTD.0000000000000994
• Languages: English
• ISSNs: 0163-4356

Abstract

Abstract : Background: Sampling of blood at home to determine the concentration of drugs or other compounds can be effective in limiting hospital-based sampling. This could lower hospital visits and patient burden, improve the quality of life, and reduce health care costs. Dried blood spot (DBS) microsampling is often used for this purpose, wherein capillary blood, obtained by pricking the heel or finger, is used to measure different analytes. Although DBS has several advantages over venous blood sampling, it is not routinely implemented in clinical practice. To facilitate the bench to bedside transition, it is important to be aware of certain challenges that need to be considered and addressed. Results: Here, important considerations regarding the implementation of DBS in clinical practice, the choice of patients, blood sampling, transport, and laboratory analysis are discussed. In addition, we share our experience and provide suggestions on how to deal with these problems in a clinical setting.